万邦德：子公司获得防治阿尔茨海默病、皮肤光老化的发明专利

Core Viewpoint - Wanbond's subsidiary has obtained a patent for a novel composition aimed at treating Alzheimer's disease and skin photoaging, highlighting innovation in drug development [1] Group 1: Patent Acquisition - Wanbond's wholly-owned subsidiary, Wanbond Pharmaceutical Group Co., Ltd., has received an invention patent certificate from the National Intellectual Property Administration [1] - The patent is for a composition and formulation that combines ginseng, ginkgo biloba leaves, and a specific herb, representing a first-class new drug compound [1] Group 2: Product Characteristics - The patented composition is characterized by high safety, low dosage, simple drug composition, and improved efficacy compared to existing single-agent medications [1] - The innovative therapy integrates multiple components, targets, and pathways to intervene in the pathological network of Alzheimer's disease, offering a superior treatment option for patients [1]